Distinct lung cell signatures define the temporal evolution of diffuse alveolar damage in fatal COVID-19.
Milross L, Hunter B, McDonald D, Merces G, Thomson A, Hilkens CMU, Wills J, Rees P, Jiwa K, Cooper N, Majo J, Ashwin H, Duncan CJA, Kaye PM, Bayraktar OA, Filby A, Fisher AJ.
Milross L, et al.
EBioMedicine. 2024 Jan;99:104945. doi: 10.1016/j.ebiom.2023.104945. Epub 2023 Dec 23.
EBioMedicine. 2024.
PMID: 38142637
Free PMC article.